Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Clovis Oncology Inc (NASDAQ:CLVS)

16.00
Delayed Data
As of May 25
 +0.42 / +2.70%
Today’s Change
11.58
Today|||52-Week Range
116.75
-54.29%
Year-to-Date
Kyle Bass Purchases Stake in Clovis Oncology
May 25 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close15.58
Today’s open15.65
Day’s range15.51 - 16.11
Volume1,438,596
Average volume (3 months)1,322,549
Market cap$598.1M
Dividend yield--
Data as of 05/25/2016

Growth & Valuation

Earnings growth (last year)-107.42%
Earnings growth (this year)+17.86%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book1.99

Competitors

 Today’s
change
Today’s
% change
CORTCorcept Therapeutics...0.000.00%
AIMTAimmune Therapeutics...+1.07+7.47%
EPZMEpizyme Inc+0.11+1.03%
DVAXDynavax Technologies...0.000.00%
Data as of 05/25/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$2.14
Annual revenue (last year)$0.00
Annual profit (last year)-$352.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Patrick J. Mahaffy
VP, Chief Financial &
Accounting Officer
Daniel W. Muehl
Corporate headquarters
Boulder, Colorado

Forecasts

Partner Offers

Search for Jobs